SBIR/STTR Research Award

RegendoGEL for guided pulp and dentin regeneration

Award identifier c8d8d8c14c2df86514f2013156431ad745fac9582ab31f9971f7e2583ff02cc4Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$398,785

Program and phase

STTR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
REGENDODENT, INC.
Proposal award date
2024-12-01
Contract end date
2025-11-30
UEI
UV79NBHXAQP3
Solicitation number
PA23-232
Topic code
NIDCR

Research abstract

Project summary/abstract RegendoGEL (RG) is a new class of dental material that stimulates both dental pulp and dentin regeneration via the biological activities of natural tooth-derived proteins. RG is being developed to regenerate dental pulp and dentin damaged by decay or trauma. RG is envisioned as a novel product to replace currently used nondegradable silicate cements. RG will initially be validated for use in vital pulp therapy, and eventually for full endodontic root canal therapy and dentin restoration. Clinically, RG will be applied in the same manner as currently used products for vital pulp and pulpotomy therapies. RG stimulates the guided regeneration of the pulp dentin complex, as validated in in vitro and in three different in vivo animal models. RG induces rapid and controllable formation of a reparative dentin bridge immediately adjacent to the product, while at the same time promoting controlled and non-inflammatory regeneration of the underlying dental pulp. RG therefore enables “controlled and guided” regeneration of pulp and dentin at predetermined locations, a concept that is akin to periodontal guided tissue regeneration therapies. The proposed STTR award will compare the original RG, which was formulated using bovine-derived dentin matrix molecules (DMMs), with a new formulation of RG containing porcine-derived DMMs. It is desirable from a cGMP manufacturing perspective to have animal-derived material from only one species. Also in Specific Aim 1, we will characterize and compare the effect of a direct restorative (resin-modified glass ionomer) on pulp and dentin regeneration in RG-MP treated teeth and compare that to teeth treated with both RG and MTA. In Specific Aim 2, we will characterize two antimicrobials: one inorganic colloidal silver nanoparticles, and the other polymeric in its composition, namely Epsilon-poly-L-lysine (ε-PL). We will then test the antimicrobial effect in a bacteria-challenged in vivo pulpotomy model. Ultimately, we propose that this combination of materials will result in the first and only biodegradable hydrogel product for endodontic therapy that is both antimicrobial, immunomodulatory and regenerative in the market.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.